Also categorized in Business of Medicine:
Facebook Asked to Remove 'Factually Inaccurate' Ads about PrEP
x hide permanently

The first U.S. trials in people put CRISPR to the test in 2019

Science News

www.sciencenews.org

When it was unveiled in 2012, people had great hopes that the gene editor CRISPR/Cas9 could treat or even cure hundreds to thousands of genetic diseases. This year, researchers in the United States began testing the gene editor in people, a crucial first step in determining whether the technology can fulfill its medical promise.

These first clinical trials are testing CRISPR/Cas9’s safety and efficacy against cancer, blood disorders and one form of inherited blindness in people who already have the disease (SN: 8/31/19, p. 6). Many more such trials are expected to ...